1-3 of 3
Ali-Nuri Huenerlituerkoglu
Close
Sort by
Journal Articles

Poor Prognosis for Patients after Myelo- and Non-Myeloablative Conditioning Therapy Followed by Allogeneic Peripheral Blood Stem Cell Transplantation Admitted to Intensive Care Unit.

Frank Neumann, Oliver Lobitz, Roland Fenk, Mustafa Kondakci, Thorsten Graef, Ingmar Bruns, Malte Kelm, Ali-Nuri Huenerlituerkoglu, Rainer Haas, Guido Kobbe
Journal: Blood
Blood (2006) 108 (11): 3678.
https://doi.org/10.1182/blood.V108.11.3678.3678
Published: 2006
Journal Articles

Comparison of Interferon Versus Thalidomide Versus RIC Allotransplant for Maintenance /Consolidation Therapy after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: A Single Center Experience.

Roland Fenk, MD, Thorsten Graef, MD, Ingmar Bruns, MD, Leilani Ruf, MD, Zohren Fabian, MD, Ulrich Steidl, MD, Ali-Nuri Huenerlituerkoglu, MD, Rainer Haas, Guido Kobbe, MD
Journal: Blood
Blood (2005) 106 (11): 1168.
https://doi.org/10.1182/blood.V106.11.1168.1168
Published: 2005
Journal Articles

Long-Term Follow-Up of a Randomized Phase III Multicenter Study Comparing a Standard Versus an Intensified Conditioning Regimen for High-Dose Chemotherapy in Patients with Multiple Myeloma.

Roland Fenk, MD, Peter Schneider, MD, Martin Kropff, MD, Ali-Nuri Huenerlituerkoglu, MD, Ulrich Steidl, MD, Carlo Aul, MD, Axel Heyll, MD, Rainer Haas, MD, Guido Kobbe, MD
Journal: Blood
Blood (2004) 104 (11): 945.
https://doi.org/10.1182/blood.V104.11.945.945
Published: 2004